Loading...
Idorsia Ltd
IDIA.SW•SIX
Healthcare
Biotechnology
CHF3.49
CHF0.00(0.00%)
Idorsia Ltd (IDIA.SW) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Idorsia Ltd (IDIA.SW), covering cash flow, earnings, and balance sheets.
Revenue Growth
-26.17%
↓ 26.17%
Operating Income Growth
9.07%
↑ 9.07%
Net Income Growth
11.47%
↑ 11.47%
Operating Cash Flow Growth
41.17%
↑ 41.17%
Operating Margin
-125.62%
↓ 125.62%
Gross Margin
52.44%
↑ 52.44%
Net Profit Margin
-146.01%
↓ 146.01%
ROE
20.43%
↑ 20.43%
ROIC
-154.06%
↓ 154.06%
Idorsia Ltd (IDIA.SW) Income Statement & Financial Overview
View the income breakdown for Idorsia Ltd IDIA.SW across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $58.88M | $59.90M | $22.70M | $16.35M |
| Cost of Revenue | $2.44M | $52.60M | $14.97M | $5.06M |
| Gross Profit | $56.44M | $7.29M | $7.74M | $11.29M |
| Gross Profit Ratio | $0.96 | $0.12 | $0.34 | $0.69 |
| R&D Expenses | $27.45M | $32.71M | $30.91M | $34.37M |
| SG&A Expenses | $52.40M | $66.80M | $55.94M | $73.97M |
| Operating Expenses | -$10.22M | $85.55M | $86.85M | $108.34M |
| Total Costs & Expenses | -$7.78M | $138.16M | $115.83M | $113.40M |
| Interest Income | $0.00 | $0.00 | -$6.17M | $0.00 |
| Interest Expense | $7.54M | $5.46M | $5.07M | $4.38M |
| Depreciation & Amortization | $4.33M | $4.20M | $4.86M | $4.22M |
| EBITDA | $75.38M | -$54.85M | -$78.14M | -$99.72M |
| EBITDA Ratio | $1.28 | -$0.92 | -$3.44 | -$6.10 |
| Operating Income | $66.67M | -$78.25M | -$89.63M | -$97.05M |
| Operating Income Ratio | $1.13 | -$1.31 | -$3.95 | -$5.94 |
| Other Income/Expenses (Net) | -$3.15M | -$5.89M | -$11.24M | -$11.27M |
| Income Before Tax | $63.51M | -$84.14M | -$100.86M | -$108.32M |
| Income Before Tax Ratio | $1.08 | -$1.40 | -$4.44 | -$6.63 |
| Income Tax Expense | $393000.00 | -$136000.00 | $173000.00 | $251000.00 |
| Net Income | $63.12M | -$84.005M | -$101.00M | -$108.57M |
| Net Income Ratio | $1.07 | -$1.40 | -$4.45 | -$6.64 |
| EPS | $0.33 | -$0.45 | -$0.56 | -$0.60 |
| Diluted EPS | $0.23 | -$0.45 | -$0.55 | -$0.60 |
| Weighted Avg Shares Outstanding | $188.89M | $188.21M | $181.58M | $179.90M |
| Weighted Avg Shares Outstanding (Diluted) | $182.45M | $188.30M | $182.38M | $179.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan